Literature DB >> 14755598

Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis.

Massimo Filippi1, Maria A Rocca, Domenico M Mezzapesa, Angelo Ghezzi, Andrea Falini, Vittorio Martinelli, Giuseppe Scotti, Giancarlo Comi.   

Abstract

Using functional magnetic resonance imaging (fMRI), we investigated whether movement-associated functional changes of the brain are present in patients who are, most likely, at the earliest stage of multiple sclerosis (MS). Functional MRI exams were obtained from 16 patients at presentation with clinically isolated syndromes (CIS) suggestive of MS and 15 sex- and age-matched healthy volunteers during the performance of three simple and one more complex motor tasks with fully normal functioning extremities. fMRI analysis was performed using statistical parametric mapping (SPM99). Compared to healthy volunteers, CIS patients had increased activations of the contralateral primary sensorimotor cortex (SMC), secondary somatosensory cortex (SII), and inferior frontal gyrus (IFG), when performing a simple motor task with the dominant hand. The increased recruitment of the contralateral primary SMC was also found during the performance of the same motor task with the non-dominant hand and with the dominant foot. In this latter case, an anterior shift of the center of activation of this region was detected. During the performance of a complex motor task with the dominant upper and lower limbs, CIS patients had an increased recruitment of a widespread network (including the frontal lobe, the insula, the thalamus), usually considered to function in motor, sensory, and multimodal integration processing. The comparison of brain activations during the performance of simple vs. complex motor tasks showed that the movement-associated somatotopic organization of the cerebral and cerebellar cortices was retained in patients with CIS. Cortical reorganization occurs in patients at presentation with CIS highly suggestive of MS. Local synaptic reorganization, recruitment of parallel existing pathways, and reorganization of distant sites are all likely to contribute to the observed functional changes. Hum. Brain Mapping 21:106-115, 2004. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14755598      PMCID: PMC6872084          DOI: 10.1002/hbm.10160

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  42 in total

1.  Relating axonal injury to functional recovery in MS.

Authors:  H Reddy; S Narayanan; P M Matthews; R D Hoge; G B Pike; P Duquette; J Antel; D L Arnold
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  The role of lateral premotor-cerebellar-parietal circuits in motor sequence control: a parametric fMRI study.

Authors:  Bernhard Haslinger; Peter Erhard; Florian Weilke; Andrés O Ceballos-Baumann; Peter Bartenstein; Helga Gräfin von Einsiedel; Markus Schwaiger; Bastian Conrad; Henning Boecker
Journal:  Brain Res Cogn Brain Res       Date:  2002-04

3.  Simultaneous early processing of sensory input in human primary (SI) and secondary (SII) somatosensory cortices.

Authors:  J Karhu; C D Tesche
Journal:  J Neurophysiol       Date:  1999-05       Impact factor: 2.714

4.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

Authors:  J I O'Riordan; A J Thompson; D P Kingsley; D G MacManus; B E Kendall; P Rudge; W I McDonald; D H Miller
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

5.  Functional magnetic resonance imaging of complex human movements.

Authors:  S M Rao; J R Binder; P A Bandettini; T A Hammeke; F Z Yetkin; A Jesmanowicz; L M Lisk; G L Morris; W M Mueller; L D Estkowski
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.

Authors:  N De Stefano; S Narayanan; G S Francis; R Arnaoutelis; M C Tartaglia; J P Antel; P M Matthews; D L Arnold
Journal:  Arch Neurol       Date:  2001-01

8.  Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage.

Authors:  Maria A Rocca; Andrea Falini; Bruno Colombo; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

Review 9.  The role of the basal ganglia in motor control: contributions from PET.

Authors:  D J Brooks
Journal:  J Neurol Sci       Date:  1995-01       Impact factor: 3.181

10.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Authors:  Peter A Brex; Olga Ciccarelli; Jonathon I O'Riordan; Michael Sailer; Alan J Thompson; David H Miller
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

View more
  17 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis.

Authors:  Maria A Rocca; Domenico M Mezzapesa; Angelo Ghezzi; Andrea Falini; Vittorio Martinelli; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

Review 3.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

4.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Authors:  Maria A Rocca; Martina Absinta; Angelo Ghezzi; Lucia Moiola; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

5.  Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue. A kinematic and functional MRI study.

Authors:  Maria Assunta Rocca; Roberto Gatti; Federica Agosta; Paola Broglia; Paolo Rossi; Elisa Riboldi; Manuela Corti; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

6.  A Short and Distinct Time Window for Recovery of Arm Motor Control Early After Stroke Revealed With a Global Measure of Trajectory Kinematics.

Authors:  Juan C Cortes; Jeff Goldsmith; Michelle D Harran; Jing Xu; Nathan Kim; Heidi M Schambra; Andreas R Luft; Pablo Celnik; John W Krakauer; Tomoko Kitago
Journal:  Neurorehabil Neural Repair       Date:  2017-03-16       Impact factor: 3.919

Review 7.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

8.  Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis.

Authors:  O Ciccarelli; A T Toosy; J F Marsden; C M Wheeler-Kingshott; D H Miller; P M Matthews; A J Thompson
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

9.  Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis.

Authors:  Domenico M Mezzapesa; Maria A Rocca; Mariaemma Rodegher; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2008-05       Impact factor: 5.038

Review 10.  The prognostic utility of MRI in clinically isolated syndrome: a literature review.

Authors:  C Odenthal; A Coulthard
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.